Get the Stockscreener App
1.4905
0.84%
-0.0295
Jupiter Neurosciences Inc stock is traded at $1.4905, with a volume of 48,132.
It is down -0.84% in the last 24 hours and down -6.96% over the past month.
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
See More
Previous Close:
$1.52
Open:
$1.53
24h Volume:
48,132
Relative Volume:
0.10
Market Cap:
$49.32M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-16.90
EPS:
-0.0882
Net Cash Flow:
-
1W Performance:
+21.56%
1M Performance:
-6.96%
6M Performance:
+120.04%
1Y Performance:
+0.00%
1-Day Range:
$1.45
$1.59
1-Week Range:
$1.20
$1.66
52-Week Range:
$0.51
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Name
Jupiter Neurosciences Inc
Sector
Industry
Phone
(561) 406-6154
Address
1001 NORTH US HWY 1, JUPITER
Compare JUNS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.49 | 41.05M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.48 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.52 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.21 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
695.47 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
316.06 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Jupiter Neurosciences Inc Stock (JUNS) Latest News
Jupiter Neurosciences (JUNS) Surges 17% on High-Profile Partnership with NBA Legend Chris Webber – Is This the Catalyst for a Longevity Market Breakout? - AInvest
Combining price and volume data for Jupiter Neurosciences Inc.Portfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
Multi asset correlation models including Jupiter Neurosciences Inc.Market Growth Review & Capital Protection Trading Alerts - Newser
Analyzing recovery setups for Jupiter Neurosciences Inc. investorsJuly 2025 PreEarnings & Growth Focused Entry Point Reports - Newser
Real time scanner hits for Jupiter Neurosciences Inc. explainedJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - Newser
Will Jupiter Neurosciences Inc. benefit from macro trendsRate Hike & Low Risk Investment Opportunities - Newser
Intrinsic Value of Jupiter Neurosciences Inc. Stock: Is It Undervalued or OvervaluedEarnings Summary Report & Breakout Confirmation Alerts - Newser
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia™ Brand - NewMediaWire
Jupiter Neurosciences launches Nugevia MND to support cognitive function and brain health - Nutritional Outlook
Jupiter Neurosciences Inc. recovery potential after sell offJuly 2025 Movers & Expert Approved Momentum Ideas - Newser
Jupiter Neurosciences names NBA Legend Chris Webber as second Nugevia brand ambassador - Mass Market Retailers
Jupiter Neurosciences Launches Nugevia™ Longevity Supplement Line to Accelerate Revenue While Developing CNS Treatments - citybuzz -
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand - FinancialContent
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador - GlobeNewswire
5-Time NBA All-Star Chris Webber Partners with Jupiter Neurosciences for $8T Longevity Market Push - Stock Titan
When is the best time to buy Jupiter Neurosciences Inc. stockWeekly Loss Report & High Return Stock Watch Alerts - Newser
Jupiter Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Chart based analysis of Jupiter Neurosciences Inc. trendsPortfolio Value Report & Expert Verified Stock Movement Alerts - Newser
Jupiter Neurosciences Inc. stock prediction for this weekQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Is Jupiter Neurosciences Inc. Starting a New UptrendQuarterly Portfolio Summary & AI Driven Stock Price Forecasts - 선데이타임즈
Will Jupiter Neurosciences Inc. Bounce From 52 Week Low2025 Price Momentum & Fast Moving Stock Watchlists - newsimpact.co.kr
Recovery Signals Appearing in Jupiter Neurosciences Inc. ChartsEntry Point & Capital Efficiency Focused Ideas - sundaytimes.kr
Visual trend scoring systems applied to Jupiter Neurosciences Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser
Why Jupiter Neurosciences Inc. stock attracts strong analyst attentionTrade Performance Summary & AI Enhanced Market Trend Forecasts - thegnnews.com
Is Jupiter Neurosciences Inc. stock poised for growthJuly 2025 Update & Consistent Return Strategy Ideas - Newser
Is Jupiter Neurosciences Inc. a Top Dividend Stock to Watch in 2025Trend Reversal & Daily Stock Momentum Reports - Newser
Is a relief rally coming for Jupiter Neurosciences Inc. holdersJuly 2025 Spike Watch & Growth Focused Investment Plans - Newser
Applying chart zones and confluence areas to NLY.PRF2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
What to do if you’re stuck in URGNJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
Real time breakdown of Jupiter Neurosciences Inc. stock performanceCPI Data & Free Community Supported Trade Ideas - Newser
Can Jupiter Neurosciences Inc. disrupt its industryWeekly Stock Recap & Weekly Top Gainers Alerts - newsyoung.net
Will earnings trigger a reversal in FVNNUDollar Strength & High Return Stock Watch Alerts - Newser
SBXD stock prediction for this weekWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Is now a turning point for Jupiter Neurosciences Inc.Quarterly Market Review & Fast Gaining Stock Reports - Newser
Jupiter Neurosciences Reports Delay in Q2 Financial Filing - AInvest
Jupiter Neurosciences Inc Stock (JUNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Jupiter Neurosciences Inc Stock (JUNS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silva Alison D. | Pres + Chief Business Officer |
Jul 01 '25 |
Buy |
1.03 |
750 |
772 |
112,777 |
| ROSEN CHRISTER | CEO and Chairman |
Jul 01 '25 |
Buy |
1.02 |
3,600 |
3,667 |
11,078,892 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
110,227 |
0 |
110,227 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 30 '25 |
Buy |
1.03 |
950 |
978 |
112,027 |
| Silva Alison D. | Pres + Chief Business Officer |
Jun 27 '25 |
Buy |
1.03 |
850 |
877 |
111,077 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 02 '25 |
Option Exercise |
0.00 |
973,466 |
0 |
11,067,476 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 30 '25 |
Buy |
1.02 |
7,650 |
7,810 |
11,075,292 |
| ROSEN CHRISTER | CEO and Chairman |
Jun 27 '25 |
Buy |
1.06 |
166 |
176 |
11,067,642 |
1.49%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):